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KLB is associated with alcohol drinking, and its gene product β-klotho is 1 
necessary for FGF21 regulation of alcohol preference 2 
 3 
Excessive alcohol consumption is a major public health problem worldwide. We 4 
conducted a genome-wide association meta-analysis and replication study among 105,898 5 
individuals of European ancestry, and identified a novel locus associated with alcohol 6 
consumption in β-Klotho (KLB) (rs11940694; P=9.2x10-12), a component of Fibroblast-7 
Growth-Factor-Receptors for FGF19/21. We show genotype-dependent alcohol preference 8 
in klb brain-specific knock-out mice compared with controls, and demonstrate that the effect 9 
of FGF21 on alcohol drinking depends on β-Klotho.  10 
 11 
Excessive alcohol consumption is a major public health problem worldwide causing an 12 
estimated 3.3 million deaths in 20121. Much of the behavioral research associated with alcohol has 13 
focused on alcohol-dependent patients. However, the burden of alcohol-associated disease largely 14 
reflects the amount of alcohol consumption in a population, not alcohol dependence2; it has long 15 
been recognized that small shifts in the mean of a continuously distributed behavior such as alcohol 16 
drinking can have major public health benefits3. For example, a shift from heavy to moderate 17 
drinking could have beneficial effects on cardiovascular disease risk4. 18 
 19 
Alcohol drinking is a heritable complex trait5. Genetic variants in the alcohol and aldehyde-20 
dehydrogenase gene family (ADH/ALDH) can result in alcohol intolerance mediated by altered 21 
peripheral metabolism of alcohol. However, genetic influences on brain functions affecting 22 
drinking behavior have been more difficult to detect because, as for many complex traits, the effect 23 
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of individual genes is small, so large sample sizes are required to detect the genetic signal6. Here 24 
we report a genome-wide association (GWAS) and replication study of over 100,000 individuals 25 
of European descent and functional characterization in a mouse knock-out. We identified a variant 26 
in a novel gene in a pathway previously described to regulate macronutrient preference. We then 27 
functionally characterized this pathway in a knock-out mouse model.  28 
 29 
We carried out GWAS of quantitative data on alcohol intake among up to 70,460 individuals 30 
(60.9% women) of European descent from 30 cohorts. We followed up the most significantly 31 
associated SNPs (six sentinel SNPs P<1.0x10-6 from independent regions) among up to 35,438 32 
individuals from 14 additional cohorts (see Supplementary Note and Supplementary Table 1). We 33 
analyzed both continuous data on daily alcohol intake in drinkers (g/day, log transformed) and a 34 
dichotomous variable of heavy vs. light or no drinking (see Online Methods and Supplementary 35 
Table 1). Average alcohol intake in drinkers across the samples was 14.0 g/day in men and 6.0 36 
g/day in women. We performed per cohort sex-specific and combined-sex single SNP regression 37 
analyses under an additive genetic model, and conducted meta-analysis across the sex-specific 38 
strata and cohorts using an inverse variance weighted fixed effects model.  39 
 40 
 Results of the primary GWAS for log g/day alcohol are shown in Table 1, Supplementary 41 
Figure 1, and Supplementary Table 2A. We identified five SNPs for replication at P<1x10-6 42 
(Supplementary Table 2A). In addition to rs10950202 in AUTS2 (P=2.9x10-7), we took forward 43 
SNP rs6943555 in AUTS2 (P=1.4x10-4), which was previously reported in relation to alcohol 44 
drinking6. Combining discovery and replication data, we report genome-wide significance for SNP 45 
rs11940694 (A/G) in KLB (P=9.2x10-12) (Table 1, Supplementary Figure 2), for which the minor 46 
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allele A was associated with reduced drinking. In the dichotomous analysis primary GWAS 47 
(Supplementary Table 2B), we took forward two SNPs (rsXXXX and rsYYYY) for replication, 48 
but neither replicated (Supplementary Table 3).  49 
 50 
KLB is localized on human chromosome 4p14 and encodes a transmembrane protein, 51 
lotho, which is an essential component of oligomeric receptors for FGF19 and FGF217,8. 52 
lotho is abundantly expressed in liver and adipose tissue, and is also expressed in discrete 53 
regions of the brain9. In mice FGF15 (homologue of FGF19) is expressed at high levels in the 54 
brain during embryogenesis and has been shown to promote neurogenesis and early brain structural 55 
development10,11. In adult mice, FGF21 is secreted from the liver in response to nutritional stress 56 
such as starvation and high-carbohydrate diets and acts co-ordinately on multiple tissues, including 57 
the brain, to regulate metabolism and related behaviors7,8.  Among its actions, FGF21 suppresses 58 
sweet preference by acting on the brain12,13. FGF21 has been associated with macronutrient 59 
preference in man14. 60 
 61 
SNP rs11940694 is localized in intron 1 of the KLB gene. We found no association of 62 
rs11940694 with gene expression in peripheral blood of 5,236 participants of the Framingham 63 
study15 (Supplementary Table 4).  64 
 65 
To examine whether β-Klotho affects alcohol drinking in mice, and whether it does so through 66 
actions in the brain, we measured alcohol intake and the alcohol preference ratio of brain-specific β-67 
Klotho-knockout (KlbCamk2a) mice and control floxed Klb (Klbfl/fl) mice. We used a voluntary two-68 
bottle drinking assay performed with water and alcohol. Since we previously showed that FGF21-69 
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transgenic mice, which express FGF21 at pharmacologic levels, have a reduced alcohol preference12, 70 
we performed these studies while administering either recombinant FGF21 or vehicle by osmotic 71 
minipump. Alcohol preference vs. water was significantly increased in vehicle-treated KlbCamk2a 72 
compared to Klbfl/fl mice at 16 vol. % alcohol (Figure 1A). FGF21 suppressed alcohol preference 73 
in Klbfl/fl mice, but not in KlbCamk2a demonstrating that the effect of FGF21 on alcohol drinking 74 
depends on β-Klotho expressed in the brain (Figure 1A). There was a corresponding decrease in 75 
plasma alcohol levels immediately after 16 vol. % alcohol drinking, which reflects the modulation 76 
of the drinking behavior (Figure 1B). However, plasma FGF21 levels were comparable in Klbfl/fl 77 
and Klb
Camk2a 
mice administered recombinant FGF21 at the end of the experiment (Figure 1C). 78 
Alcohol bioavailability was not different between FGF21 treated Klbfl/fl and Klb
Camk2a 
mice (Figure 79 
1D). We have previously shown that FGF21 decreases the sucrose and saccharine preference ratio 80 
in Klbfl/fl but not Klb
Camk2a 
mice, and has no effect on the quinine preference ratio12. To rule out a 81 
potential perturbation of our findings as a result of the experimental procedure, we independently 82 
measured preference and consumption of 16 vol. % alcohol in Klbfl/fl and KlbCamk2a mice without 83 
implantation of an osmotic minipump. Again, KlbCamk2a mice showed significantly greater alcohol 84 
consumption and increased alcohol preference compared to Klbfl/fl mice (Figure 2A,B), thus 85 
replicating our findings above. Alcohol bioavailability after an i.p. injection was not different between 86 
Klbfl/fl and KlbCamk2a mice after 1 and 3 hours (Figure 2C).  87 
 88 
Increased alcohol drinking in humans and mice may be motivated by its reward properties 89 
or as a means to relieve anxiety16. FGF21 increases corticotrophin release factor and catecholamine 90 
release in mice17, which is linked to heightened anxiety. We therefore tested Klbfl/fl and KlbCamk2a 91 
mice in behavioral paradigms measuring anxiety, including novelty suppressed feeding 92 
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(Supplementary Figure 4A), elevated plus maze (Supplementary Figure 4B), and open field activity 93 
tests (Supplementary Figure 4C) but did not find differences between Klbfl/fl and KlbCamk2a mice in 94 
any of the anxiety measures, or in general locomotor activity.  Our finding of increased alcohol 95 
preference in KlbCamk2a mice may thus be caused by alteration of alcohol-associated reward 96 
mechanisms. This notion is consistent with our previous results showing Klb expression in areas 97 
important for alcohol reinforcement, specifically the nucleus accumbens and the ventral tegmental 98 
area12. 99 
 100 
Here we report results from genome-wide data in over 100,000 individuals that SNP 101 
rs11940694 in KLB associates with alcohol consumption. In functional animal experiments we 102 
show that β-Klotho controls alcohol drinking through a central nervous system mechanism 103 
involving the action of FGF21 that is secreted in the liver. Whereas most previous studies 104 
investigating the mechanisms underlying alcohol drinking behavior have focused on investigations 105 
of brain (or liver) functions alone, our results suggest the possibility of a coordinated action across 106 
the two organ systems, liver and brain. This FGF21-KLB axis may be involved in regulation of 107 
complex adaptive behaviors involving alcohol drinking.   108 
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ONLINE METHODS 109 
Alcohol phenotypes 110 
Alcohol intake in grams of alcohol per day was estimated by each cohort based on information 111 
about drinking frequency and type of alcohol consumed. For cohorts that collected data in 112 
‘drinks per week’, standard ethanol contents in different types of alcohol drinks were provided as 113 
guidance to convert the data to ‘grams per week’, which was further divided by 7 to give intake 114 
as ‘grams per day’. Adjustment was made if cohort-specific drink sizes differed from the 115 
standard. For cohorts that collected alcohol use in grams of ethanol per week, the numbers were 116 
divided by 7 directly into ‘grams per day’. Cohorts with only a categorical response to the 117 
question for drinks per week used mid-points of each category for the calculation. All non-118 
drinkers (individuals reporting zero drinks per week) were removed from the analysis. The 119 
‘grams per day’ variable was then log10 transformed prior to the analysis. Sex-specific residuals 120 
were derived by regressing alcohol in log10(grams per day) in a linear model on age, age-square, 121 
weight, and if applicable, study site and principal components to account for population 122 
structure. The sex-specific residuals were pooled and used as the main phenotype for subsequent 123 
analyses.  124 
Dichotomous alcohol phenotype was created based on categorization of ‘drinks per week’ 125 
variable. Heavy drinking was defined as >=21 drinks per week in men, or >=14 drinks per week 126 
in women. Light (or zero) drinking was defined if male participants had <=14 drinks per week, 127 
or female participants had <=7 drinks per week. Drinkers having >14 to <21 drinks for men, or 128 
>7 to <14 drinks for women were excluded. Where information was available, current non-129 
drinker who was former drinker of >14 drinker per week in men, and >7 drinks per week in 130 
women, as well as current non-drinker who was a former drinker of unknown amount were 131 
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excluded; whereas current non-drinkers who were former drinkers of <=14 for men or <=7 for 132 
women were included.  Further exclusion was made if there were missing data on alcohol 133 
consumption or on the covariates. The analyses only included participants of European origin.  134 
Discovery GWAS in AlcGen and CHARGE+ and replication analyses 135 
Genotyping methods are summarized in Supplementary Table 1B, 1C and 1F.  SNPs were 136 
excluded if: HWE P < 1x10-6 or based on cohort-specific criteria; MAF < 1%; imputation 137 
information score < 0.5; if results were only available from 2 or fewer cohorts, or total N < 10,000. 138 
Population structure was accounted for within cohorts via principal components analysis (PCA). 139 
LD score regression18 was conducted on the GWAS summary results to examine the degree of 140 
inflation in test statistics, and genomic control correction was considered unnecessary (λGC=1.06 141 
and intercept=1.00; λ=0.99 to 1.06 for individual cohorts, Supplementary Table 1B, 1C). SNPs 142 
were taken forward for replication from discovery GWAS if they passed the above criteria and if 143 
they had P < 1x10-6 (one SNP with the smallest P taken forward in each region, except for AUTS2 144 
for which two SNPs were taken forward based on previous results6). Meta-analyses were 145 
performed by METAL19 or R (v3.2.2).  146 
Gene Expression Profiling in Framingham study 147 
In the Framingham study, gene expression profiling was undertaken for the blood samples of a 148 
total of 5,626 participants from the Offspring (N=2,446) at examination eight and the Third 149 
Generation (N=3,180) at examination two. Fasting peripheral whole blood samples (2.5ml) were 150 
collected in PAXgene™ tubes (PreAnalytiX, Hombrechtikon, Switzerland). RNA expression 151 
profiling was conducted using the Affymetrix Human Exon Array ST 1.0 (Affymetrix, Inc., Santa 152 
Clara, CA) for samples that passed RNA quality control. The expression values for ~ 18,000 153 
transcripts were obtained from the total 1.2 million core probe sets. Quality control procedures for 154 
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transcripts have been described previously. All data used herein are available online in dbGaP 155 
(http://www.ncbi.nlm.nih.gov/gap; accession number phs000007). 156 
 157 
The cis- Expression Quantitative Trait Loci Analysis in Framingham study  158 
To investigate possible effects of rs11940694 in KLB on gene expression, we performed cis-eQTL 159 
analysis. The SNP in KLB was used as the independent variable in association analysis with the 160 
transcript of KLB measured using whole blood samples in the FHS (n=5,236). Affymetrix probe 161 
2724308 was used to represent the KLB overall transcript levels. Age, sex, BMI, batch effects and 162 
blood cell differentials were included as covariates in the association analysis. Linear mixed model 163 
was used to account for familial correlation in association analysis.  164 
 165 
Mouse studies 166 
klb knock-out: All mouse experiments were approved by the Institutional Animal Care and 167 
Research Advisory Committee of the University of Texas Southwestern Medical Center. Male 168 
littermates (2 to 4-month-old) maintained on a 12 hr light/dark cycle with ad libitum access to 169 
chow diet (Harlan Teklad TD2916) were used for all experiments. The Klb gene was deleted from 170 
brain by crossing Klbfl/fl mice with Camk2a-Cre mice on a mixed C57BL/6J;129/Sv background 171 
as described9. 172 
 173 
Alcohol drinking in mice 174 
For voluntary two-bottle preference experiments, male mice (n=9-13 per group) were given access 175 
to two bottles, one containing water and the other containing 2-16% ethanol (vol/vol) in water. 176 
After acclimation to the two-bottle paradigm, mice were exposed to each concentration of ethanol 177 
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for 4 days. Total fluid intake (water + ethanol-containing water), food intake and body weight were 178 
measured each day. Alcohol consumption (g) was calculated based on EtOH density (0.789 g/ml). 179 
To obtain accurate alcohol intake that corrected for individual differences in littermate size, 180 
alcohol consumption was normalized by body weight per day for each mouse. As a measure of 181 
relative alcohol preference, the preference ratio was calculated at each alcohol concentration by 182 
dividing total consumed alcohol solution (ml) by total fluid volume. Two-bottle preference assays 183 
were also performed with sucrose (0.5 and 5%) and quinine (2 and 20 mg/dl) solutions. For all 184 
experiments, the positions of the two bottles were changed every two days to exclude position 185 
effects.  186 
 187 
Mouse experiments with native FGF21 188 
For FGF21 administration studies, recombinant human FGF21 protein provided by Novo Nordisk 189 
was administered at a dose of 0.7 mg/kg/day by subcutaneous osmotic mini-pumps (Alzet 1004). 190 
Mice were single caged following mini-pump surgery, which was conducted under isoflurane 191 
anesthesia and 24 hour buprenorphine analgesia. Mice were allowed to recover from mini-pump 192 
surgery for 4 days prior to alcohol drinking tests. After experiments, mice were sacrificed by 193 
decapitation and plasma was collected using EDTA or heparin after centrifugation for 15 minutes 194 
at 3000 rpm. Plasma FGF21 concentrations were measured using the Biovendor FGF21 ELISA 195 
Kit according to manufacturer’s protocol. 196 
 197 
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Plasma ethanol concentration and clearance 198 
For alcohol bioavailability tests, mice (n=4-5 per group) were injected i.p. with alcohol (2.0 g/kg, 199 
20% w/vol) in saline, and tail vein blood was collected after 1 and 3 hours. Plasma alcohol 200 
concentrations were measured using the EnzyChrom™ Ethanol Assay Kit. 201 
 202 
Emotional behavior in mice 203 
For open field activity assays, naïve mice were placed in an open arena (44 cm2, with the center 204 
defined as the middle 14 cm2 and the periphery defined as the area 5 cm from the wall), and the 205 
amount of time spent in the center versus along the walls and total distance traveled were 206 
measured. For elevated plus maze activity assays, mice were placed in the center of a plus maze 207 
with 2 dark enclosed arms and 2 open arms. Mice were allowed to move freely around the maze, 208 
and the total duration of time in each arm and the frequency to enter both the closed and open arms 209 
was measured. For novelty suppression of feeding assays, mice fasted for 12 hours were placed in 210 
a novel environment and the time to approach and eat a known food was measured. 211 
 212 
Statistical Analysis 213 
All data are expressed as means ± S.E.M. Statistical analysis between the two groups was 214 
performed by unpaired two-tailed Student's t test using Excel or GraphPad Prism (GraphPad 215 
Software, Inc.). For multiple comparisons, one-way analysis of variance (ANOVA) with post-hoc 216 
Tukey was done using SPSS.  217 
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